Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

REIMAGINE 1, 2, 3: Leveraging Amylin and GLP-1 for Type 2 Diabetes Care with CagriSema

Authors :

John B. Buse¹; Steven E. Kahn²; Vanita R. Aroda³; Akshay Jain^{4, 5}; Julio Rosenstock⁶

Affiliations

View Details Hide Details

Keywords

Diabetes

Congress oral presentation

Amylin

GLP-1 RA

CagriSema

PHASE 3 (RCT)